rs75054132
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000298910.12(LRRK2):c.225G>A(p.Ala75=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000283 in 1,613,576 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A75A) has been classified as Likely benign.
Frequency
Consequence
ENST00000298910.12 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRK2 | NM_198578.4 | c.225G>A | p.Ala75= | synonymous_variant | 2/51 | ENST00000298910.12 | NP_940980.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRK2 | ENST00000298910.12 | c.225G>A | p.Ala75= | synonymous_variant | 2/51 | 1 | NM_198578.4 | ENSP00000298910 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00151 AC: 230AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000430 AC: 108AN: 251204Hom.: 1 AF XY: 0.000302 AC XY: 41AN XY: 135798
GnomAD4 exome AF: 0.000155 AC: 226AN: 1461352Hom.: 1 Cov.: 32 AF XY: 0.000138 AC XY: 100AN XY: 727010
GnomAD4 genome AF: 0.00151 AC: 230AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.00160 AC XY: 119AN XY: 74424
ClinVar
Submissions by phenotype
Autosomal dominant Parkinson disease 8 Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 10, 2023 | - - |
Uncertain significance, no assertion criteria provided | curation | GeneReviews | Sep 13, 2012 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 14, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at